Newron Pharmaceuticals SpA(CH:NWRN)
CHF 8.92-0.08 (-0.89%)
CH:NWRN
Newron Pharmaceuticals SpA financials statements
CHF 8.92
At close:-0.08 (-0.89%)
Want to see CH:NWRN full AI Analyst Report?
Newron Pharmaceuticals SpA (NWRN) Income Statement
7 Followers
Newron Pharmaceuticals SpA Income Statement
Last quarter (Q2 2026), Newron Pharmaceuticals SpA's total revenue was €3.17M, a decrease of 6.85% from the same quarter last year. In Q2, Newron Pharmaceuticals SpA's net income was €-16.29M. See Newron Pharmaceuticals SpA’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| € 19.13M | € 51.39M | € 9.06M | € 6.09M | € 5.76M | |
| € 19.13M | € 51.39M | € 9.06M | € 6.09M | € 5.76M | |
| € 23.81M | € 25.22M | € 20.69M | € 19.40M | € 18.12M | |
| Depreciation and Amortization | € 173.12K | € 192.00K | € 201.00K | € 202.00K | € 209.00K |
| € -4.55M | € 25.94M | € -11.83M | € -13.32M | € -11.76M | |
| € -4.70M | € 26.17M | € -11.63M | € -13.30M | € -12.36M | |
| € -7.66M | € -4.78M | € -4.57M | € -4.17M | € -2.53M | |
| € -12.35M | € 21.39M | € -16.20M | € -17.47M | € -14.88M | |
| € -13.24M | € 15.84M | € -16.22M | € -17.49M | € -14.90M | |
| Per Share Metrics | |||||
| Basic EPS | € -0.67 | € 0.85 | € -0.91 | € -0.98 | € -0.84 |
| Diluted EPS | € -0.67 | € 0.85 | € -0.91 | € -0.98 | € -0.84 |
| Weighted Average Shares Outstanding | 19.96M | 18.56M | 17.84M | 17.84M | 17.84M |
| Weighted Average Shares Outstanding (Diluted) | 19.96M | 18.56M | 17.84M | 17.84M | 17.84M |
Currency in EUR
